Carnegie Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Carnegie Investment Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Sell	1,930 -70	-4%	-$39.3K	0.02%	311
2026 Q1	$1.12M	Buy	2,000 +25	+1%	+$16K	0.02%	309
2025 Q4	$1.34M	Hold	1,975	–	–	0.02%	298
2025 Q3	$1.26M	Hold	1,975	–	–	0.02%	292
2025 Q2	$1.06M	Hold	1,975	–	–	0.02%	300
2025 Q1	$814K	Buy	+1,975	New	+$858K	0.02%	309
2024 Q4	–	Sell	-405	Closed	-$205K	–	472
2024 Q3	$205K	Buy	+405	New	+$197K	0.01%	454
2024 Q2	–	Sell	-400	Closed	-$216K	–	483
2024 Q1	$216K	Sell	400 -1	-0.2%	-$546	0.01%	468
2023 Q4	$223K	Buy	+401	New	+$188K	0.01%	458
2023 Q3	–	Sell	-401	Closed	-$201K	–	491
2023 Q2	$201K	Sell	401 -175	-30%	-$83.9K	0.01%	481
2023 Q1	$288K	Sell	576 -1	-0.2%	-$479	0.01%	441
2022 Q4	$235K	Buy	+577	New	+$224K	0.01%	459
2022 Q3	–	Sell	-597	Closed	-$209K	–	486
2022 Q2	$209K	Sell	597 -419	-41%	-$171K	0.01%	448
2022 Q1	$556K	Buy	1,016 +124	+14%	+$65.2K	0.02%	331
2021 Q4	$587K	Sell	892 -103	-10%	-$64.7K	0.02%	336
2021 Q3	$619K	Hold	995	–	–	0.02%	292
2021 Q2	$628K	Buy	995 +20	+2%	+$11K	0.02%	298
2021 Q1	$477K	Buy	975 +275	+39%	+$138K	0.02%	323
2020 Q4	$350K	Hold	700	–	–	0.02%	340
2020 Q3	$275K	Hold	700	–	–	0.01%	354
2020 Q2	$231K	Buy	+700	New	+$203K	0.01%	375

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Carnegie Investment Counsel's IDXX Position: Q2 2026 in Review

Carnegie Investment Counsel reduced its Idexx Laboratories (IDXX) stake by 3.5% in Q2 2026, selling an estimated $39.3K and leaving 1,930 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #311.

Carnegie Investment Counsel first reported a position in IDXX in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.34M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Carnegie Investment Counsel held 1,930 shares of Idexx Laboratories worth $1.02M as of Q2 2026.
Carnegie Investment Counsel sold 70 Idexx Laboratories shares in Q2 2026, an estimated $39.3K.
Idexx Laboratories made up 0.02% of Carnegie Investment Counsel's portfolio in Q2 2026, its #311 holding.
Carnegie Investment Counsel first reported a position in Idexx Laboratories in Q2 2020 and has held it in 21 quarters since.
Carnegie Investment Counsel's Idexx Laboratories position peaked at $1.34M in Q4 2025.
715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.